Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients
Purpose: To evaluate effectiveness and safety of cataract surgery pharmacological support (which include 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) in glaucoma patients. Patients and Methods: Standard ophthal...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2018-10-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/697 |
id |
doaj-b95fb5d31fef4dd399bd9a46da85bb3c |
---|---|
record_format |
Article |
spelling |
doaj-b95fb5d31fef4dd399bd9a46da85bb3c2021-07-29T08:55:26ZrusOphthalmology Publishing GroupOftalʹmologiâ 1816-50952018-10-0115333033810.18008/1816-5095-2018-3-330-338460Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma PatientsS. V. Yanchenko0A. V. Malyshev1S. N. Sakhnov2G. Yu. Karapetov3Kuban State Medical University; Scientific Research Institution — S.V. Ochapovsky Regional Clinic Hospital No. 1Kuban State Medical University; Scientific Research Institution — S.V. Ochapovsky Regional Clinic Hospital No. 1Kuban State Medical University; The Krasnodar branch IRTC “Eye Microsurgery” named after Acad. S.N. Fyodorov KrasnykhScientific Research Institution — S.V. Ochapovsky Regional Clinic Hospital No. 1Purpose: To evaluate effectiveness and safety of cataract surgery pharmacological support (which include 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) in glaucoma patients. Patients and Methods: Standard ophthalmological examination, subjective discomfort level evaluation, tear film break up time, tear meniscus height measurement, index of xerosis, evaluation and ocular surface condition photoregistration were performed in 40 II «A» primary open-angle glaucoma patients, receiving hypotensive therapy, before and after phacoemulsification (Ph). All patients in the postoperative period received instillations: 0.5 % levofloxacin (4 times a day, 7 days), 0.1 % dexamethasone (3 times a day, 7 days), 0.09 % bromfenac (once a day, 30 days) and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination (3 times a day, 30 days). Control points were: examination before Ph, on 1, 7 and 30 days after Ph. Results: None cases of infectious or inflammatory surgery complications were recorded. The SD level was significantly increased on the 1 and 7 days after Ph, by the 30 day the SD level was significantly decreased, compared with a state on the 1 and 7 days. On the 1, 7, 30 days after Ph TFBUT significantly decreased. By the 30 day after Ph the TFBUT was significantly increased in compare with 1 and 7 days after operation. TMH changes after Ph had multidirectional character and in general were not significant throughout the observation, with a tendency to increase on the 1 and 30 days after surgery and to decrease on the 7th day. IX dynamics in compare with a state before Ph was not significant in all control points with a tendency to its increase on the 1 and 7 days after operation and to decrease on the 30th day. In general, pharmacological support of Ph was assessed by all patients as comfortable, there was no intolerance. Conclusion: The cataract surgery pharmacological support in glaucoma patients (including 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) showed: high efficiency (in prevention of infectious and inflammatory complications); safety by influence on the ocular surface; comfort of use.https://www.ophthalmojournal.com/opht/article/view/697cataract surgeryglaucomapharmacological supportocular surface0.09 % bromfenac |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
S. V. Yanchenko A. V. Malyshev S. N. Sakhnov G. Yu. Karapetov |
spellingShingle |
S. V. Yanchenko A. V. Malyshev S. N. Sakhnov G. Yu. Karapetov Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients Oftalʹmologiâ cataract surgery glaucoma pharmacological support ocular surface 0.09 % bromfenac |
author_facet |
S. V. Yanchenko A. V. Malyshev S. N. Sakhnov G. Yu. Karapetov |
author_sort |
S. V. Yanchenko |
title |
Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients |
title_short |
Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients |
title_full |
Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients |
title_fullStr |
Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients |
title_full_unstemmed |
Effectiveness and Safety of Cataract Surgery Pharmacological Support in Glaucoma Patients |
title_sort |
effectiveness and safety of cataract surgery pharmacological support in glaucoma patients |
publisher |
Ophthalmology Publishing Group |
series |
Oftalʹmologiâ |
issn |
1816-5095 |
publishDate |
2018-10-01 |
description |
Purpose: To evaluate effectiveness and safety of cataract surgery pharmacological support (which include 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) in glaucoma patients. Patients and Methods: Standard ophthalmological examination, subjective discomfort level evaluation, tear film break up time, tear meniscus height measurement, index of xerosis, evaluation and ocular surface condition photoregistration were performed in 40 II «A» primary open-angle glaucoma patients, receiving hypotensive therapy, before and after phacoemulsification (Ph). All patients in the postoperative period received instillations: 0.5 % levofloxacin (4 times a day, 7 days), 0.1 % dexamethasone (3 times a day, 7 days), 0.09 % bromfenac (once a day, 30 days) and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination (3 times a day, 30 days). Control points were: examination before Ph, on 1, 7 and 30 days after Ph. Results: None cases of infectious or inflammatory surgery complications were recorded. The SD level was significantly increased on the 1 and 7 days after Ph, by the 30 day the SD level was significantly decreased, compared with a state on the 1 and 7 days. On the 1, 7, 30 days after Ph TFBUT significantly decreased. By the 30 day after Ph the TFBUT was significantly increased in compare with 1 and 7 days after operation. TMH changes after Ph had multidirectional character and in general were not significant throughout the observation, with a tendency to increase on the 1 and 30 days after surgery and to decrease on the 7th day. IX dynamics in compare with a state before Ph was not significant in all control points with a tendency to its increase on the 1 and 7 days after operation and to decrease on the 30th day. In general, pharmacological support of Ph was assessed by all patients as comfortable, there was no intolerance. Conclusion: The cataract surgery pharmacological support in glaucoma patients (including 0.5 % levofloxacin, 0.09 % bromfenac and preservative free polyvinylpyrrolidone and polyvinyl alcohol fixed combination instillations) showed: high efficiency (in prevention of infectious and inflammatory complications); safety by influence on the ocular surface; comfort of use. |
topic |
cataract surgery glaucoma pharmacological support ocular surface 0.09 % bromfenac |
url |
https://www.ophthalmojournal.com/opht/article/view/697 |
work_keys_str_mv |
AT svyanchenko effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients AT avmalyshev effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients AT snsakhnov effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients AT gyukarapetov effectivenessandsafetyofcataractsurgerypharmacologicalsupportinglaucomapatients |
_version_ |
1721251080191344640 |